secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0000012208-23-000054
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad completes $650M share repurchase program; plans additional authorization in Q3
--------------------------------------------------------------------------------

- Q2-to-date repurchased $207.4M of Class A common stock, 549,863 shares at avg $377.20.
- Aggregate repurchases reach the $650M limit authorized by Board in Nov 2017, July 2020, and July 2022.
- Management intends to seek Board approval for additional repurchase authority in Q3 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000054/0000012208-23-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000054/bio-20230605.htm
  HTML page:      https://secwatch.observer/filing/0000012208-23-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer